major
lymphocyt
activ
mucos
site
receiv
instruct
home
back
local
mucosa
portion
also
seed
distal
mucosa
site
seed
distal
site
antigenspecif
effector
memori
lymphocyt
foundat
laid
anim
mucos
immun
system
respond
secondari
respons
antigen
encount
site
futur
common
mucos
immun
system
studi
quit
extens
rodent
model
less
larg
anim
model
pig
reason
pauciti
report
induct
common
mucos
immun
system
speci
may
distal
mucos
site
examin
induct
observ
therefor
report
howev
suspect
major
investig
simpli
sampl
distal
mucos
site
therefor
littl
evid
immun
respons
induct
literatur
hope
pig
immunologist
infecti
diseas
expert
perform
mucos
immun
inocul
pig
sampl
distal
mucos
site
report
find
whether
result
posit
neg
review
highlight
paper
show
immunizationinocul
use
one
rout
trigger
mucos
immun
system
induct
local
system
within
least
one
distal
mucos
site
understand
whether
immun
one
site
trigger
immun
throughout
common
mucos
immun
system
ration
develop
vaccin
pig
work
gather
evid
mucos
immun
system
may
extrapol
livestock
speci
human
mucosalassoci
immun
system
malt
includ
conjunctiva
conjunctivaassoci
lymphoid
tissu
calt
lacrim
ductalt
ldalt
larynxalt
lalt
salivari
ductalt
sdalt
nasalalt
nalt
bronchusalt
balt
gutalt
galt
vagin
valt
gebert
pabst
although
compon
malt
anatom
function
distinct
share
trait
organ
induct
site
cell
present
antigen
via
antigenpres
cell
apc
anim
major
porcin
pathogen
gain
entri
bodi
mucos
surfac
ingest
inhal
feed
environ
fecal
contamin
system
vaccin
intramuscular
intraperiton
subcutan
rout
etc
gener
promot
mucos
immun
therefor
anim
immun
system
combat
pathogen
gain
entri
bodi
mestecki
mestecki
et
al
murtaugh
thu
mucos
immun
potenti
control
pathogen
point
entri
would
advantag
develop
vaccin
trigger
strong
mucos
system
immun
respons
rather
simpli
stimul
system
immun
system
induct
local
mucos
immun
respons
gut
exampl
antigen
taken
intestin
dc
migrat
mesenter
lymph
node
mln
lead
antigenspecif
b
lymphocyt
activ
annack
et
al
fujimoto
et
al
johanssonlindbom
et
al
schulz
et
al
upon
activ
lymphocyt
undergo
prolifer
differenti
mammal
activ
clonal
lymphocyt
exit
mln
via
effer
lymph
drain
thorac
caviti
enter
circul
pig
invert
lymph
node
therefor
immigr
lymph
node
tissu
take
place
either
affer
lymph
vessel
high
endotheli
venul
hev
emigr
directli
circul
hev
binn
pabst
circul
major
activ
lymphocyt
home
back
site
antigen
initi
encount
kiyono
fukuyama
kunisawa
et
al
lefrancoi
et
al
svensson
et
al
dc
play
critic
role
regul
express
home
molecul
surfac
activ
lymphocyt
johanssonlindbom
et
al
stock
et
al
intestin
migratori
mhcii
dc
produc
retino
acid
ra
promot
express
activ
lymphocyt
mice
human
campbel
butcher
johanssonlindbom
et
al
mora
et
al
mora
et
al
stagg
et
al
stock
et
al
yokota
et
al
receptor
madcam
highli
enrich
endothelium
vasculatur
suppli
small
intestin
lymphocyt
bear
undergo
extravas
postcapillari
venul
berlin
et
al
lymphocyt
turn
home
small
intestin
epitheli
cell
constitut
express
ligand
kunkel
et
al
lazaru
et
al
home
iga
produc
b
cell
divers
mucos
tissu
appear
mediat
ligand
lazaru
et
al
contrast
skinderiv
dc
imprint
express
pand
eselectin
ligand
activ
lymphocyt
campbel
butcher
campbel
et
al
schon
et
al
lung
dc
imprint
express
lymphocyt
promot
home
lung
mikhak
et
al
thu
major
activ
lymphocyt
home
back
site
antigen
uptak
dc
importantli
portion
activ
lymphocyt
seed
mucos
tissu
outsid
local
mucosa
tremend
valuabl
distal
mucos
site
may
also
encount
pathogen
ie
sourc
antigen
futur
brandtzaeg
et
al
campbel
et
al
kunkel
butcher
adopt
transfer
experi
anim
shown
cell
obtain
mucos
tissu
donat
syngen
anim
preferenti
repopul
recipi
mucos
tissu
compel
evid
common
mucos
immun
system
griscelli
et
al
hall
et
al
mcdermott
bienenstock
weiszcarrington
et
al
activ
antigen
mucos
induct
site
lead
effector
andor
memori
b
cell
distal
mucos
site
refer
function
connect
basi
common
mucos
immun
system
kiyono
fukuyama
kunisawa
et
al
mcghee
et
al
tabl
due
hostil
environ
gastrointestin
tract
coupl
propens
oral
immun
system
respond
toler
oral
antigen
substanti
challeng
elicit
protect
mucos
immun
respons
gut
use
oral
immun
faria
et
al
faria
weiner
strobel
ferguson
strobel
mowat
sever
physic
barrier
prevent
antigenpathogen
contact
gutassoci
lymphoid
tissu
galt
penetr
gut
wall
mucou
product
peristalt
movement
gut
secret
natur
antibacteri
substanc
lysozym
host
defens
peptid
protect
intestin
surfac
bacteri
penetr
extrem
ph
environ
stomach
proteas
rich
environ
small
intestin
compromis
immunogen
ingest
antigen
medina
pasetti
et
al
also
antibodi
compon
matern
colostrummilk
may
interfer
antigen
uptak
andor
function
brandtzaeg
snoeck
et
al
therefor
one
could
design
vaccin
activ
common
mucos
immun
system
would
tremend
advantag
initi
mucos
immun
oral
antigen
respiratori
genit
mucosa
activ
lymphocyt
would
migrat
oral
mucosa
protect
gastrointestin
tract
major
mucos
vaccin
compris
replic
attenu
pathogen
although
effect
potenti
revert
virul
wwwvetvacorgindexphp
diseas
porcin
respiratori
reproduct
syndrom
viru
prrsv
econom
devast
pig
barn
outbreak
occur
liveattenu
vaccin
administ
seroneg
herd
even
though
unlik
attenu
viru
revert
virul
consid
great
risk
vaccin
proactiv
therefor
prrsv
vaccin
administ
pig
barn
outbreak
thu
vaccin
proactiv
administ
botner
et
al
hu
zhang
storgaard
et
al
one
may
specul
reason
attenu
pathogen
effect
mucos
vaccin
may
order
trigger
oral
immun
respons
instead
toler
pathogen
must
travers
gut
wall
andor
penetr
epitheli
cell
line
gut
wall
howev
research
shown
subunit
vaccin
formul
adjuv
cholera
toxin
ct
trigger
mucos
immun
pig
work
describ
within
murtaugh
hyland
et
al
verdonck
et
al
b
review
present
manuscript
evid
vaccin
andor
inocul
pig
one
mucos
site
trigger
measur
immun
respons
within
local
mucosa
within
blood
within
least
one
distal
mucos
immun
site
exampl
research
wherein
pig
expos
replic
attenu
viru
via
intranas
rout
show
virusspecif
igg
iga
antibodi
product
cellmedi
immun
respons
within
respiratori
mucosa
ie
local
mucosa
oral
vagin
mucosa
distal
mucosa
well
blood
system
immun
respons
would
meet
criteria
report
local
mucos
immun
site
andor
seros
respons
report
ie
intranas
vaccin
piglet
report
antibodi
product
bronchoalveolar
lavag
fluid
andor
blood
report
includ
review
intend
review
thorough
examin
literatur
report
evid
induct
common
mucos
immun
respons
pig
awar
howev
approach
sever
limit
outlin
first
intranas
immun
may
inde
also
peror
portion
vaccin
swallow
case
interpret
evid
antibodi
gut
truli
induct
distal
mucos
site
galt
directli
stimul
therefor
consid
local
mucosa
unfortun
imposs
discern
whether
suffici
precaut
taken
ensur
exclus
intranas
immun
report
trust
report
ie
rout
intranas
reason
confid
common
mucos
immun
system
induc
report
intranas
immun
also
report
immun
distal
site
oral
mucos
immun
system
second
approach
evalu
protect
immun
respons
induct
antigenspecif
igg
iga
titer
presenc
antibodysecret
cell
asc
andor
induct
antigenspecif
cellmedi
immun
induct
express
lymphocyt
prolifer
report
unfortun
major
manuscript
examin
report
antibodi
product
without
correl
presenc
asc
organ
thu
awar
possibl
iga
igg
antibodi
may
blood
transport
distal
mucos
site
via
receptor
pigr
fcrn
respect
kaetzel
et
al
raghavan
et
al
stirl
et
al
thirdli
antigen
deliv
part
replic
bacteria
yeast
viru
possibl
exist
pathogenvector
dissemin
unless
pathogen
strict
tissuetrop
andor
antigen
present
distal
mucos
site
migrat
activ
dc
care
examin
type
dc
may
take
antigen
zhang
et
al
local
mucosa
includ
adhes
molecul
ie
whether
specif
nasalbronchorespiratori
tract
digest
tract
etc
could
shed
light
antigen
migrat
thu
review
divid
section
discuss
manuscript
show
direct
evid
induct
common
mucos
immun
system
ie
asc
distal
site
andor
induct
cellmedi
immun
first
follow
manuscript
show
indirect
evid
ie
antibodi
titer
within
categori
discuss
nonrepl
replic
vaccin
final
pleas
note
includ
discuss
mammaryentero
link
influenc
mammari
secret
gut
immun
system
review
subject
suggest
follow
excel
public
bourg
et
al
bourg
et
al
levast
et
al
salmon
salmon
et
al
pig
inocul
intranas
day
oral
challeng
oocyst
veg
strain
day
immedi
prior
challeng
two
pig
immun
rhoptri
protein
euthan
pbmc
mln
harvest
mln
pbmc
stimul
rhoptri
protein
ex
vivo
mln
lymphocyt
show
higher
prolifer
measur
cellmedi
immun
rel
pbmc
two
pig
euthan
statist
analysi
could
perform
remain
anim
euthan
day
sever
week
challeng
vaccin
group
three
remain
four
pig
margin
igg
igarhoptri
specif
antibodi
titer
blood
show
partial
protect
tissu
cyst
burden
conclud
intranas
immun
crude
rhoptri
protein
gondii
use
quila
adjuv
pig
abl
stimul
common
mucos
immun
respons
partial
protect
anim
brain
cyst
format
oral
exposur
gondii
oocyt
da
cunha
et
al
oronas
administr
attenu
transmiss
gastroenter
coronaviru
tgev
porcin
respiratori
coronaviru
follow
oral
tgev
challeng
brim
et
al
saif
vancott
et
al
transmiss
gastroenter
coronaviru
tgev
porcin
coronaviru
although
infect
respiratori
tract
primarili
replic
intestin
tract
caus
sever
diarrhea
dehydr
death
brim
et
al
saif
et
al
porcin
respiratori
coronaviru
prcv
replic
almost
exclus
upper
lower
respiratori
tract
pig
caus
subclin
mild
respiratori
infect
brim
et
al
otool
et
al
pensaert
et
al
saif
stone
et
al
pig
inocul
oralnas
tgev
prcv
day
age
piglet
challeng
tgev
oral
rout
day
day
ppi
vancott
et
al
piglet
oronas
expos
tgev
develop
diarrhea
shed
viru
rectum
lesser
shed
nasal
passag
brim
et
al
vancott
et
al
pig
protect
clinic
sign
diseas
challeng
contrast
piglet
immun
prcv
show
clinic
sign
diseas
primari
immun
shed
viru
nasal
secret
suggest
prcv
replic
respiratori
tract
gastrointestin
tract
vancott
et
al
prcv
vaccin
anim
partial
protect
tgev
challeng
effect
cell
popul
assess
piglet
prime
tgev
respond
challeng
strike
increas
percentag
lesser
extent
cell
mln
duodenum
ileum
major
replic
site
tgev
limit
increas
bronchial
lymph
node
bln
spleen
rel
number
cell
found
agematch
unexpos
pig
brim
et
al
prolif
respons
mln
cell
prcvinocul
pig
lower
mln
cell
primari
secondari
tgevexpos
pig
despit
fact
number
cell
bln
appear
increas
group
pig
prime
tgev
prcv
magnitud
tgev
prcvspecif
prolifer
highest
bln
cell
group
immedi
prior
challeng
bln
prcvinocul
pig
prolif
respons
gener
remain
high
tgev
challeng
correl
protect
nasal
viru
shed
contrast
bln
cell
tgevreinocul
pig
show
signific
transient
decreas
prolifer
return
high
level
harvest
pig
protect
viru
shed
nasal
secret
challeng
prcv
tgevinocul
pig
well
tgevchalleng
pig
show
signific
lymphocyt
prolifer
respons
prcv
tgevin
lamina
propria
cell
purifi
duodenum
jejunum
ileum
humor
immun
respons
measur
pig
oronas
prime
tgev
bln
spleen
mln
ileum
show
higher
ratio
igg
iga
asc
highest
igg
asc
observ
bln
vancott
et
al
higher
iga
igg
asc
ratio
detect
duodenum
jejunum
prior
challeng
vancott
et
al
measur
asc
show
bln
spleen
elev
iga
igg
asc
challeng
presenc
iga
asc
gut
lamina
propria
tgevprim
pig
time
challeng
correl
complet
protect
tgev
challeng
vancott
et
al
immun
respons
gener
piglet
prime
oronas
rout
prcv
quit
differ
respons
gener
piglet
prime
tgev
prcvexpos
pig
mainli
igg
asc
bln
limit
number
ileum
duodenum
jejunum
show
small
number
iga
asc
wherea
site
virtual
iga
asc
challeng
tgev
five
twelv
prcvprime
pig
develop
diarrhea
show
increas
iga
asc
bln
spleen
duodenum
jejunum
iga
asc
detect
ileum
none
detect
mln
importantli
number
igg
asc
increas
rapidli
gut
lamina
propria
mln
bln
alreadi
fairli
high
igg
asc
data
may
indic
prcvspecif
igg
asc
precursor
balt
prcvprime
pig
migrat
gut
respons
tgev
challeng
contribut
partial
protect
thu
unlik
shown
rabbit
rodent
galtderiv
iga
b
cell
major
migratori
cell
among
mucos
lymphoid
tissu
thought
migrat
readili
balt
galt
mcghee
et
al
sminia
et
al
data
vancott
et
al
indic
virusspecif
igg
asc
memori
b
cell
rapidli
accumul
gut
lamina
propria
mln
prcvprime
pig
tgev
challeng
like
migrat
balt
vancott
et
al
oral
immun
actinobacillu
pleuropneumonia
live
kill
impact
lymphocyt
subset
distribut
bronchoalveolar
space
asc
lavag
fluid
sera
delventh
et
al
pabst
et
al
experi
four
month
old
german
landrac
pig
spf
breed
farm
use
delventh
et
al
pabst
et
al
lavag
control
group
n
lavag
week
one
five
six
without
immun
delventh
et
al
pabst
et
al
anoth
nonimmun
control
group
lavag
infect
aerosol
challeng
lavag
one
week
later
experiment
pig
lavag
follow
oral
immun
activ
inact
irradi
bacteria
delventh
et
al
pabst
et
al
group
except
lavag
control
group
infect
aerosol
challeng
viabl
app
week
five
lavag
one
week
later
experiment
group
lavag
week
seven
eight
well
result
show
nonimmun
pig
sever
ill
infect
app
show
massiv
patholog
necropsi
within
one
week
infect
wherea
anim
immun
viabl
inactiv
appear
clinic
normal
lavag
control
group
show
signific
differ
number
cell
bronchoalveolar
bal
fluid
differenti
lymphocyt
subset
rel
anim
oral
immun
inactiv
bacteria
pig
immun
viabl
bacteria
show
trend
toward
higher
number
nucleat
cell
increas
proport
granulocyt
compar
composit
macrophag
constant
proport
lymphoid
blast
plasma
cell
found
bal
normal
pig
plasma
cell
blast
rare
percentag
plasma
cell
bal
increas
significantli
oral
immun
either
viabl
nonviabl
bacteria
delventh
et
al
pabst
et
al
immun
either
viabl
noviabl
bacteria
trigger
overal
increas
total
number
cell
ratio
cell
remain
constant
signific
increas
iga
asc
bal
immun
inactiv
bacteria
signific
increas
igg
igm
asc
pig
oral
immun
viabl
nonviabl
bacteria
thu
oral
administr
either
viabl
inactiv
pleuropneumonia
induc
influx
lymphocyt
bronchoalveolar
compart
pig
indic
migrat
gut
lamina
propria
bronchi
trachea
airway
delventh
et
al
pabst
et
al
gnotobiot
pig
alter
intestin
structur
reduc
villou
length
increas
crypt
depth
proinflammatori
cytokin
gene
express
rel
convent
rear
piglet
shirkey
et
al
piglet
show
sign
clinic
diseas
patholog
human
rotaviru
hrv
make
valuabl
anim
model
studi
mucos
system
immun
respons
rotaviru
azevedo
et
al
gonzalez
et
al
iosef
et
al
saif
et
al
ward
et
al
yuan
et
al
yuan
et
al
yuan
et
al
mutant
escherichia
coli
heatlabil
toxin
mlt
adjuv
gnotobiot
pig
follow
oral
challeng
yuan
et
al
gnotobiot
pig
day
age
administ
vaccin
via
intranas
rout
twice
interv
immun
vaccin
antigen
compris
viruslik
particl
deriv
bovin
simian
strain
refer
bsvlp
without
g
mlt
mucos
adjuv
deriv
e
coli
yuan
et
al
mlt
includ
vaccin
refer
bsvlp
therefor
pig
immun
twice
intranas
bsvlp
without
mlt
refer
bsvlp
mlt
includ
refer
bsvlp
dose
repeat
twice
mlt
refer
control
pig
mock
inocul
salin
mlt
alon
day
igm
iga
igg
asc
number
duodenum
ileum
pig
immun
intranas
higher
pig
immun
without
mlt
mean
number
igm
igg
asc
ileum
pig
immun
significantli
higher
immun
without
mlt
data
suggest
intranas
administr
antigen
mucos
adjuv
promot
robust
mucos
immun
intestin
site
yuan
et
al
day
piglet
challeng
oral
infecti
dose
id
virul
wa
hrv
compar
animalspecif
prechalleng
asc
number
pig
immun
mlt
show
signific
induct
antigenspecif
asc
respons
duodenum
ileum
indic
induct
memori
respons
yuan
et
al
remark
intranas
inocul
pig
induc
higher
number
intestin
iga
igg
asc
memori
bcell
respons
three
oral
dose
live
attenu
wa
hrv
yuan
et
al
yuan
et
al
yuan
saif
despit
respons
pig
immun
protect
diarrhea
produc
significantli
enhanc
virusneutr
antibodi
titer
compar
challeng
control
pig
clearli
intranas
immun
gnotobiot
piglet
trigger
mucos
immun
mlt
adjuv
includ
vaccin
protect
determin
whether
magnitud
immun
respons
could
influenc
number
dose
subgroup
specif
vlp
three
five
day
old
gnotobiot
pig
vaccin
intranas
three
dose
bsvlp
refer
three
dose
vlp
bovin
strain
rf
labb
et
al
vlp
virul
wa
human
rotaviru
presenc
mlt
refer
yuan
et
al
second
third
dose
administ
day
asc
respons
induc
regimen
ie
bovinesimian
vlp
show
similar
pattern
intestin
system
lymphoid
tissu
signific
differ
magnitud
compar
pig
inocul
twice
bsvlp
pig
immun
ie
bovinehuman
vlp
induc
mean
number
igg
asc
mean
number
iga
asc
duodenum
ileum
compar
prechalleng
suggest
strain
antigen
deriv
human
simian
impact
immun
challeng
mean
number
iga
igg
asc
pig
immun
increas
significantli
compar
prechalleng
asc
number
tissu
except
igg
duodenum
igg
iga
bone
marrow
contrast
mean
number
iga
asc
pig
increas
significantli
duodenum
ileum
igg
asc
increas
significantli
mln
spleen
peripher
blood
bone
marrow
postchalleng
suggest
sourc
antigen
human
simian
rotaviru
impact
immun
respons
yuan
et
al
despit
data
show
immunogen
vaccin
antigen
induct
memori
b
cell
ileum
pig
immun
fail
protect
gnotobiot
pig
rotaviru
challeng
signific
differ
percentag
mean
durat
viru
shed
diarrhea
mean
day
onset
shed
mean
peak
titer
viru
shed
mean
cumul
diarrhea
score
author
specul
studi
differ
dose
time
vaccin
andor
viral
antigen
may
confer
protect
yuan
et
al
attenu
nonrepl
antigen
follow
oral
challeng
virul
human
rotaviru
gnotobiot
pig
yuan
et
al
next
research
group
explor
whether
stimul
galt
nalt
combin
oral
intranas
vaccin
rout
would
gener
superior
immun
rotaviru
challeng
rel
either
vaccin
rout
alon
oral
prime
boost
three
five
day
age
piglet
given
sodium
bicarbon
reduc
stomach
acid
oral
inocul
fluoresc
focusform
unit
ffu
attenu
wa
hrv
atthrv
follow
boost
day
day
bhvlp
plu
mlt
jointli
refer
prime
oral
boost
three
five
day
age
piglet
inocul
bhvlp
prime
dose
readminist
ten
day
later
twentyon
day
post
first
inocul
pig
given
sodium
bicarbon
oral
immun
ffu
atthrv
jointli
refer
yuan
et
al
group
piglet
oral
challeng
virul
wa
hrv
seven
day
past
inocul
pig
prime
nasal
boost
oral
show
partial
protect
clinic
sign
diseas
shorter
mean
durat
viru
shed
lower
mean
peak
viru
shed
titer
compar
mlt
mock
control
challeng
virul
wa
hrv
pig
prime
oral
boost
show
significantli
reduc
viru
shed
diarrhea
rate
compar
pig
vaccin
mlt
alon
mock
control
group
vaccin
pig
shed
viru
shorter
mean
durat
shed
cumul
fecal
score
indic
reduc
sever
diseas
result
also
indic
combin
vaccin
regimen
induc
virusspecif
igm
iga
asc
respons
lymphoid
tissu
especi
intestin
tissu
yuan
et
al
pig
prime
oral
boost
significantli
higher
igm
iga
igg
asc
respons
intestin
lymphoid
tissu
pig
prime
nasal
boost
oral
yuan
et
al
fact
pig
prime
oral
boost
show
highest
mean
number
intestin
iga
asc
challeng
among
rotaviru
vaccin
gnotobiot
pig
test
research
group
date
includ
one
three
oral
dose
live
attenu
wa
hrv
two
three
intramuscular
dose
inactiv
wa
hrv
ifa
yuan
et
al
yuan
et
al
result
suggest
oral
prime
live
attenu
wa
hrv
follow
intranas
boost
bhvlp
plu
mlt
effect
stimul
intestin
iga
asc
respons
yuan
et
al
pig
prime
oral
boost
show
significantli
higher
virusneutr
geometr
mean
titer
serum
group
yuan
et
al
summar
prime
mucos
induct
site
portal
natur
infect
replic
vaccin
follow
boost
nonrepl
vaccin
second
mucos
induct
site
stimul
strongest
bcell
respons
intestin
mucos
immun
system
challeng
confer
moder
high
protect
rate
rotaviru
diseas
yuan
et
al
subunit
kill
vaccin
oral
antigen
exposur
newborn
piglet
induc
oral
immun
respons
system
vaccin
later
life
pasternak
et
al
press
first
h
birth
gut
pig
exist
semiperm
state
facilit
uptak
matern
antibodi
macromolecul
matern
cell
lecc
matron
nechvatalova
et
al
nguyen
et
al
rook
bland
therefor
laboratori
investig
whether
subunit
vaccin
administ
stomach
caviti
within
h
birth
would
allow
antigen
travers
gut
wall
induc
oral
immun
subvert
induct
oral
toler
without
negat
stomach
acid
piglet
gavag
twopart
vaccin
consist
solubl
ova
mg
mg
g
solubl
cpg
well
polyphosphazen
microparticl
mp
encapsul
mg
ova
g
cpg
pasternak
et
al
press
piglet
gavag
less
h
age
idea
solubl
ovacpg
ovacpg
within
mp
would
cross
gut
wall
polyphosphazen
mp
watersolubl
dissolv
time
releas
ovacpg
thu
act
like
primeboost
vaccin
garlapati
et
al
mutwiri
et
al
mutwiri
et
al
except
salin
control
group
piglet
ipinject
mg
ova
plu
incomplet
freund
adjuv
ifa
day
age
piglet
euthan
day
age
ip
control
group
receiv
salin
gavag
boost
ip
vaccin
therefor
act
primari
system
vaccin
control
group
salin
control
piglet
gavag
immun
salin
serum
observ
significantli
higher
antiova
group
gavag
mg
ovacpg
mp
rel
salin
control
group
time
oral
vaccin
group
show
higher
mean
titer
time
rel
ip
control
group
antiova
igm
iga
igg
although
result
statist
signific
balf
collect
time
death
result
show
piglet
gavag
lowest
dose
ovacpg
mp
show
antiova
igg
titer
statist
higher
control
group
low
titer
antiova
iga
detect
group
pasternak
et
al
press
collect
result
suggest
oral
exposur
ova
trigger
low
level
mucos
immun
distal
site
show
agreement
similar
trial
perform
neonat
rat
pup
lamb
signific
local
immun
respons
gener
buchanan
et
al
buchanan
et
al
studi
must
undertaken
clarifi
precis
dose
durat
exposur
requir
induct
mucos
immun
pig
grown
adulthood
gavag
stomach
caviti
ctb
subunit
mix
conjug
prrsv
nucleocapsid
protein
myc
peptid
hyland
et
al
hyland
et
al
block
negat
stomach
acid
product
prior
administ
vaccin
directli
stomach
caviti
four
week
old
piglet
three
time
ten
day
interv
hyland
et
al
oral
vaccin
compos
ctb
subunit
alon
ctb
coadminist
recombin
prrsv
nucleocapsid
n
protein
myc
peptid
recombin
protein
ctb
genet
fuse
n
protein
myc
protein
ctbspecif
secretori
iga
detect
intestin
mucosa
group
antiiga
specif
n
myc
detect
intestin
mucosa
minor
anim
fuse
ctb
peptid
simpli
mix
ctb
antibodi
within
intestin
mucosa
detect
suggest
link
peptid
ctb
necessari
gener
peptidespecif
iga
local
mucosa
serum
antibodi
produc
ctb
subunit
pig
well
weak
titer
antictb
antibodi
saliva
vagin
secret
distal
mucos
site
ie
gavag
bypass
oral
caviti
therefor
saliva
consid
local
mucos
site
n
protein
myc
fuse
ctb
antin
antimyc
iga
antibodi
detect
serum
saliva
vagin
secret
igg
antimyc
detect
serum
even
without
conjug
ctb
mucos
site
thu
oral
vaccin
ctb
abl
elicit
distal
iga
antibodi
respons
saliva
reproduct
tract
though
magnitud
respons
small
rel
local
mucos
antibodi
product
respons
extend
unlink
peptid
hyland
et
al
gavag
stomach
caviti
ct
ctb
subunit
coadminist
keyhol
limpet
hemocyanin
klh
conjug
ovalbumin
foss
murtaugh
foss
murtaugh
block
negat
stomach
acid
product
prior
administ
vaccin
directli
stomach
caviti
five
six
week
old
pig
three
time
seven
ten
day
interv
foss
murtaugh
five
day
final
vaccin
administ
cell
mucos
secret
collect
vaccin
consist
ct
g
per
anim
recombin
ctb
mg
per
anim
result
diarrhea
clinic
sign
toxic
oral
ctb
alon
induc
statist
signific
induct
antictb
igg
iga
titer
serum
jejun
mucosa
saliva
distal
mucosa
g
ct
ad
vaccin
robust
induct
antictb
iga
igg
titer
induc
serum
wherea
examin
jejun
mucu
show
induct
iga
titer
saliva
show
induct
igg
titer
salivari
antictb
iga
respons
also
increas
modestli
jejun
lamina
propria
investig
asc
found
contain
significantli
igasecret
cell
igg
igm
secret
cell
well
significantli
iga
secret
cell
found
blood
spleen
spleen
contain
igm
asc
lamina
propria
peripher
blood
mononuclear
cell
pbmc
less
iga
igg
asc
two
tissu
larg
number
iga
secret
cell
lamina
propria
suggest
antictb
specif
antibodi
jejun
mucu
produc
local
tissu
addit
experi
conduct
confirm
antictb
iga
measur
intestin
mucu
produc
local
anim
immun
three
time
ctb
plu
ct
lamina
propria
contain
antictb
specif
iga
antictb
specif
iga
asc
per
million
total
isol
cell
rel
amount
antictb
iga
igg
adjac
mucu
reflect
rel
number
antictb
iga
igg
asc
lamina
propria
suggest
local
product
rather
hematogen
origin
antictb
iga
igg
asc
also
detect
spleen
follow
oral
immun
much
fewer
number
lamina
propria
trend
toward
increas
igg
asc
rel
iga
asc
next
investig
evalu
whether
keyhol
limpet
hemocyanin
klh
coadminist
ctb
ovalbumin
ova
conjug
ctb
glutaraldehyd
presenc
absenc
ct
could
trigger
mucos
system
immun
oral
ct
ctb
result
antictb
iga
serum
klhspecif
asc
detect
jejun
lamina
propria
cell
foss
murtaugh
anim
receiv
ova
link
ctb
higher
level
igmantiova
asc
jejunum
serum
antiova
igm
administ
ct
unfortun
report
effect
distal
mucosa
saliva
conclud
ct
effect
oral
immunogen
safe
oral
adjuv
swine
nontox
dose
promot
stronger
mucos
immun
link
antigen
feed
oral
exposur
saccharomyc
cerevisiacod
pleuropneumonia
antigen
pig
challeng
intranas
virul
pleuropneumonia
shin
et
al
major
efficaci
oral
vaccin
compris
attenu
pathogen
research
use
yeast
saccharomyc
cerevisia
live
replic
vaccin
vector
express
protein
subunit
pathogen
interest
kim
et
al
shin
et
al
shin
colleagu
clone
pleuropneumonia
antigen
apxia
apxiia
cerevisia
shin
et
al
shin
et
al
three
week
old
piglet
fed
coloni
form
unit
cfu
cerevisia
express
apxiaapxia
cerevisia
vector
control
left
untreat
pig
control
shin
et
al
oral
vaccin
administ
three
time
separ
weekli
interv
blood
nasal
wash
fecal
sampl
collect
weekli
piglet
fed
vector
code
antigen
show
significantli
higher
antiapxia
apxiia
iga
nasal
wash
rel
pig
fed
vector
alon
untreat
pig
one
week
final
oral
vaccin
sera
antiapxiia
iga
igg
significantli
higher
vaccin
pig
rel
pig
fed
vector
control
yeast
repres
pig
challeng
intranas
one
week
final
vaccin
cfu
pleuropneumonia
serotyp
korean
vaccin
group
show
lower
clinic
sign
diseas
compar
control
group
show
reduc
number
bacteria
could
reisol
lung
although
reduct
statist
relev
nontreat
control
vector
control
group
show
microscop
lung
chang
indic
alveolar
wall
congest
inflammatori
infiltr
alveoli
fill
edema
fluid
neutrophil
indic
acut
inflammatori
respons
thu
oral
immun
yeast
code
protein
antigen
show
mucos
respons
respiratori
tract
mucosa
manifest
lower
clinic
sign
diseas
oral
vaccin
pig
live
erysipelothrix
rhusiopathia
vector
code
mycoplasma
hyponeumonia
antigen
challeng
intranas
rout
ogawa
et
al
e
rhusiopathia
koganei
strain
bacteria
colon
tonsil
pig
use
protect
pig
erysipela
ogawa
et
al
creat
recombin
e
rhusiopathia
bacteria
express
ctermin
portion
protein
hyponeumonia
ogawa
et
al
use
vaccin
eight
old
specif
pathogen
free
spf
pig
administ
milk
replac
contain
live
recombin
e
rhusiopathia
express
hyponeumonia
protein
cfugroupday
seven
consecut
day
control
two
pig
fed
milk
replac
contain
bacteria
unfortun
vector
control
group
includ
pig
challeng
intraderm
cfu
e
rhusiopathia
fujisawa
strain
day
final
day
vaccin
result
show
pig
oral
inocul
e
rhusiopathia
strain
protect
death
show
clinic
sign
infect
increas
bodi
temperatur
skin
lesion
reduc
activ
wherea
control
pig
develop
typic
sign
erysipela
die
euthan
within
seven
day
five
new
control
pig
oral
vaccin
five
pig
randomli
chosen
experiment
group
challeng
intranas
suspens
contain
colorchang
unit
ccu
hyponeumonia
three
consecut
day
four
week
final
day
vaccin
four
week
follow
challeng
exposur
pig
euthan
necropsi
proport
lung
surfac
pneumon
lesion
determin
result
show
median
proport
lung
surfac
pneumon
lesion
group
significantli
smaller
control
group
anoth
vaccin
trial
undertaken
wherein
ten
piglet
oral
inocul
three
consecut
day
e
rhusiopathia
strain
feed
pig
milk
replac
contain
bacteria
cfugroupday
nine
pig
oral
inocul
e
rhusiopathia
koganei
cfugroupday
vector
control
thirteen
day
final
vaccin
pig
challeng
intranas
suspens
ccu
hyponeumonia
three
consecut
day
twentythre
day
challeng
exposur
pig
euthan
necropsi
concentr
igg
antibodi
bal
fluid
obtain
time
necropsi
significantli
higher
vaccin
group
control
group
data
show
agreement
previou
studi
show
vaccin
pig
greater
concentr
hyponeumoniaespecif
igg
iga
titer
balf
thacker
et
al
thu
oral
vaccin
replic
pathogen
protect
pig
bacteria
administ
intranas
promot
induct
antigenspecif
humor
immun
balf
author
show
gnotobiot
piglet
oral
inocul
e
rhusiopathia
show
evid
bacteria
dissemin
lung
tracheobronchi
lymph
node
eight
day
howev
author
also
show
e
rhusiopathia
koganei
strain
oral
administ
spf
pig
dissemin
tonsil
unfortun
specifi
whether
part
tonsil
examin
pharyng
palantin
etc
mesenter
lymph
node
lung
organ
investig
day
data
support
possibl
within
vaccin
trial
bacteria
dissemin
growth
beyond
digest
caviti
ogawa
et
al
thu
antibodi
titer
balf
like
present
due
migrat
bacteria
oral
caviti
lung
time
infect
oligodeoxynucleotid
adjuv
zhang
et
al
immun
pig
intranas
attenu
prrsv
alon
cpg
oligodeoxynucleotid
odn
evalu
effect
system
mucos
immun
respons
piglet
administ
primari
intranas
vaccin
twenti
day
age
report
day
well
intranas
booster
immun
day
later
serum
secret
analyz
day
day
post
primari
immun
ppi
day
ppi
piglet
immun
prrsv
plu
g
g
cpg
odn
serum
titer
approxim
higher
total
virusspecif
igg
serum
piglet
immun
viru
alon
viru
plu
gml
gpc
odn
control
odn
inclus
cpg
odn
vaccin
trigger
higher
overal
virusspecif
titer
wherea
piglet
immun
prrsv
alon
gpc
odn
backbon
control
odn
show
higher
level
prrsvspecif
day
postimmun
thu
presenc
cpg
odn
influenc
antigenspecif
igg
isotyp
produc
prrsv
administ
alon
gpc
odn
weak
antiprrsv
iga
detect
nasal
secret
day
weak
iga
nasal
secret
oral
secret
day
antiprrsv
iga
detect
secret
salin
control
group
time
point
saliva
fece
nasal
secret
evalu
day
day
day
ppi
show
signific
antiprrsv
iga
three
secret
cpg
odn
includ
vaccin
highest
titer
observ
highest
concentr
cpg
odn
data
suggest
inclus
tolllik
receptor
agonist
cpg
odn
intranas
prrsv
vaccin
may
promot
common
mucos
immun
provid
cours
none
vaccin
administ
intranas
swallow
porcin
system
mucos
immun
respons
similar
counterpart
human
immunolog
tool
avail
assess
innat
acquir
immun
relev
vaccin
studi
inde
studi
dawson
report
porcin
immun
system
resembl
human
analyz
paramet
wherea
mice
similar
dawson
pig
import
model
studi
respiratori
diseas
lung
inflamm
cystic
fibrosi
ekser
et
al
elahi
et
al
meuren
et
al
roger
et
al
pig
human
lung
share
mani
physiolog
featur
swindl
et
al
includ
extens
interand
intralobular
connect
tissu
gil
et
al
due
differ
anim
size
develop
anatom
differ
rodent
may
share
similar
rout
dose
infect
diseas
transmiss
period
latenc
therefor
may
appropri
predict
vaccin
efficaci
human
howev
anatomi
time
mucosalassoci
lymphoid
develop
conserv
diverg
distinct
mucos
site
across
speci
instanc
tindepend
respons
mous
periton
cell
confirm
speci
bo
et
al
reynold
morri
rodent
evid
gut
pp
organogenesi
develop
utero
adachi
et
al
yet
rodent
born
minim
galt
lack
circul
b
cell
friedberg
weissman
contrast
detail
levast
et
al
piglet
born
rel
advanc
galt
structur
complet
peyer
patch
pp
undergo
expans
matur
upon
exposur
commens
flora
environment
antigen
barman
et
al
pabst
thu
convent
rais
piglet
may
gut
mucosa
suffici
matur
respond
oral
vaccin
period
immedi
birth
least
humor
immun
even
compar
mucos
immun
system
across
larg
anim
speci
differ
anatomi
function
mucos
tissu
rumin
ileal
peyer
patch
like
avian
bursa
primari
lymphoid
organ
necessari
b
cell
develop
reynold
morri
contrast
despit
share
similar
develop
utero
compris
nearli
continu
pp
birth
provid
compel
evid
pig
ipp
primari
lymphoid
organ
instead
special
secondari
lymphoid
tissu
sinkora
et
al
mice
human
pp
consid
import
secondari
lymphoid
organ
b
cell
lymphogenesi
occur
instead
fetal
liver
persist
bone
marrow
bm
corn
jung
et
al
therefor
import
assum
common
mucos
immun
system
exist
pig
base
evid
deriv
laboratori
anim
instead
look
experiment
evid
herein
provid
evid
induct
common
mucos
immun
system
local
mucosa
ie
oral
intranas
distal
mucosa
saliva
genit
tract
bronchu
gut
appropri
yet
found
evid
link
mucos
site
conjunctiva
etc
studi
must
undertaken
clarifi
impact
mucos
immun
mucos
site
done
must
defin
precis
dose
durat
exposur
requir
induct
mucos
immun
local
well
distal
site
knowledg
contribut
understand
underli
mechan
vaccin
strategi
promot
immun
import
implic
protect
infecti
diseas
pig
beyond
excel
anim
model
human
immunolog
pig
part
global
food
product
industri
therefor
health
posit
impact
global
one
health
immun
regimen
adopt
sever
factor
whether
cost
toxic
low
whether
efficaci
high
whether
vaccin
easi
administ
must
consid
control
cost
alway
consider
livestock
oper
equal
import
consid
effect
vaccin
especi
pig
outbr
popul
immun
may
trigger
optim
immun
anim
enough
show
posit
respons
herd
immun
may
protect
rest
eas
immun
tremend
impact
whether
immun
regimen
adopt
instanc
oral
intranas
immun
laborintens
oper
intravagin
immun
protect
femal
litter
piglet
grow
quickli
subsequ
booster
vaccin
necessit
piglet
snare
physic
chemic
immobil
prior
vaccin
regardless
whether
secondari
vaccin
take
place
via
oral
intranas
intravagin
rout
importantli
process
breed
gilt
sow
undergo
lordosi
respons
natur
immobil
anim
time
oral
intranas
intravagin
immun
could
easili
perform
without
snare
without
potenti
harm
barn
personnel
protect
femal
herd
lesser
extent
protect
offspr
passiv
immun
colostrum
milk
consider
must
weigh
found
labor
costeffect
mucos
immun
pig
adopt
